附件公司
US ˙ NasdaqGS ˙ US03589W1027

簡介

本頁面提供了有關 Jung Choi 已知的內部交易歷史的全面分析。內部人士包括公司的高管、董事或重要投資者。一般而言,基於內幕、非公開信息進行交易是非法的。這並不意味著他們在自己的公司進行任何交易都是非法的。但是,他們必須透過Form 4向美國證券交易委員會(SEC)報告所有交易。盡管存在這些限制,學術研究表明,內部人士 - 整體而言 - 在自己公司中的投資表現往往優於市場。

平均交易盈利能力

「平均交易盈利能力」衡量了內部人士在過去三年中所有非計劃性的公開市場購買交易的平均回報率。計算過程包括檢查每筆交易,排除了作為10b5-1交易計劃的一部分的交易。然後,對每筆交易在3、6和12個月的表現進行平均,以生成該筆交易最終的表現指標。最終,將所有交易的表現指標進行平均,計算出內部人士的總體平均表現指標。列表僅包含在過去兩年中進行過至少三筆交易的內部人士。

如果內部人士的交易盈利能力顯示為"N/A",則可能是因為該內部人士在過去三年內沒有進行任何公開市場購買交易,或者他們進行的交易距離現在太近,無法計算出可靠的表現指標。

更新頻率:每日

查看收益最高的的內幕交易者列表。

報告內部持倉的公司

SEC文件顯示Jung Choi已報告在以下公司擁有持倉或進行了交易:

證券 職位 最新報告的持倉
US:ANNX / Annexon, Inc. Director 33,000
US:GBT / Global Blood Therapeutics Inc. See Remarks 0
如何解讀這些圖表

以下圖表顯示了在Jung Choi進行的每筆公開市場非計劃交易後證券的股價表現。非計劃交易是指沒有作為10b5-1交易計劃的一部分而進行的交易。股價表現以累積百分比變化的方式繪製。例如,如果一筆內部人士交易是在2019年1月1日進行的,該圖表將顯示該證券的每日百分比變化直至當前日期。如果在此期間股價從10美元漲至15美元,則股價的累積百分比變化將為50%。從10美元漲至20美元的價格變化將為100%,而從10美元跌至5美元的價格變化將為-50%。

最終,我們將評估內部人士的交易與股價的超額回報(正向或負向)之間的相關性,以判斷內部人士是否在交易中利用內部信息獲利。如果內部人士有這樣的行為,我們預期看到(a)購買後的正回報,或者(b)賣出後的負回報。對於情況(a),購買圖表將顯示一系列向上傾斜的曲線,表示每次購買後都有正回報。對於情況(b),賣出圖表將顯示一系列向下傾斜的曲線,表示每次賣出後都有負回報。

然而,僅憑這一點還不足以得出結論。例如,如果公司的股價在多年內呈現非周期性上升,我們會預期所有購買後的圖表都呈現向上傾斜。同樣地,多年來呈現非周期性下降的股價會導致賣出後的圖表也呈現向下傾斜。這兩種情況的圖表都不能表示內部人士在進行內幕交易。

最有力的指標是在公司股價呈極度循環波動的情況下,「購買」圖表顯示正向信號,而「賣出」圖表顯示負向趨勢。這種情況強烈暗示內部人士可能根據內幕信息精確地計時進行交易,以獲得財務優勢。

ANNX / Annexon, Inc.內部人士買入 - 短期收益分析

在這一部分,我們分析了在 ANNX / Annexon, Inc. 中進行的每筆非計劃的公開市場內部人士購買的盈利情況。這種分析有助於了解內部人士是否持續產生異常的回報,以及是否值得跟踪。該分析基於每筆交易後一年的情況,結果僅為理論值

以下表格顯示了最近的自動交易計劃之外的公開市場購買。

交易日期 證券代碼 內部人士 報告
股數
Reported
價格
經調整
股數
經調整
價格
成本基礎 達到最高利潤的
天數
達到最高利潤時的
價格
最高
淨利 ($)
最高回報率(%)
2025-12-01 ANNX Choi Jung 33,000 4.1900 33,000 4.1900 138,270 52 6.9600 91,410 66.11

經調整價格 已按拆股調整。經調整股數 已按拆股調整。

ANNX / Annexon, Inc. Insider Trades
ANNX / Annexon, Inc.內部人士賣出 - 短期虧損分析

在這一部分,我們分析了在 ANNX / Annexon, Inc. 中進行的每筆非計劃的公開市場內部人士賣出所達成的短期虧損規避。如果存在持續的虧損規避模式,可能表明未來的內部人士賣出交易預示著價格的下跌。該分析基於每筆交易後一年的情況,

以下表格顯示了最近的自動交易計劃之外的公開市場購買。

交易日期 證券代碼 內部人士 報告
股數
Reported
價格
經調整
股數
經調整
價格
成本基礎 達到最低利潤的
天數
達到最低利潤時的
價格
避免的
最高損失金額($)
避免的
最高損失率($)
當前未知該內部人士及證券組合進行過任何未預先計劃的公開市場交易。

經調整價格 已按拆股調整。經調整股數 已按拆股調整。

ANNX / Annexon, Inc. Insider Trades
歷史內部人交易

該表格顯示了由 Jung Choi 進行的所有內幕交易的完整列表,這些交易已向美國證券交易委員會(SEC)披露。

呈報日期 交易日期 表格 證券代碼 證券 代碼 10b5-1 股份 剩餘股份 %
變化
每股
股價
交易
金額
剩餘
金額
2025-12-03 2025-12-01 4 ANNX Annexon, Inc.
Common Stock
P - Purchase 33,000 33,000 4.19 138,270 138,270
2022-10-06 2022-10-05 4 GBT Global Blood Therapeutics, Inc.
Common Stock
D - Sale to Issuer -25,000 0 -100.00
2022-10-06 2022-10-05 4 GBT Global Blood Therapeutics, Inc.
Common Stock
D - Sale to Issuer -226,672 0 -100.00
2022-09-29 2022-09-29 4 GBT Global Blood Therapeutics, Inc.
Common Stock
G - Gift -73,855 226,672 -24.58
2022-09-29 2022-09-27 4 GBT Global Blood Therapeutics, Inc.
Common Stock
M - Exercise 2,674 300,527 0.90 3.40 9,092 1,021,792
2022-09-29 2022-09-27 4 GBT Global Blood Therapeutics, Inc.
Common Stock
M - Exercise 2,674 300,527 0.90 3.40 9,092 1,021,792
2022-09-29 2022-09-27 4 GBT Global Blood Therapeutics, Inc.
Common Stock
M - Exercise 74,964 295,179 34.04 3.40 254,878 1,003,609
2022-09-29 2022-09-27 4 GBT Global Blood Therapeutics, Inc.
Common Stock
M - Exercise 2,275 220,215 1.04 65.82 149,740 14,494,551
2022-09-29 2022-09-27 4 GBT Global Blood Therapeutics, Inc.
Common Stock
M - Exercise 16,902 217,940 8.41 16.40 277,193 3,574,216
2022-09-06 2022-09-01 4 GBT Global Blood Therapeutics, Inc.
Common Stock
F - Taxes -1,861 201,038 -0.92 68.15 -126,827 13,700,740
2022-09-06 2022-09-01 4 GBT Global Blood Therapeutics, Inc.
Common Stock
M - Exercise 2,208 202,899 1.10
2022-09-06 2022-09-01 4 GBT Global Blood Therapeutics, Inc.
Common Stock
M - Exercise 2,763 200,691 1.40
2022-08-03 2022-08-01 4 GBT Global Blood Therapeutics, Inc.
Common Stock
F - Taxes -2,126 197,928 -1.06 32.40 -68,882 6,412,867
2022-08-03 2022-08-01 4 GBT Global Blood Therapeutics, Inc.
Common Stock
M - Exercise 6,145 200,054 3.17
2022-03-03 2022-03-01 4 GBT Global Blood Therapeutics, Inc.
Stock Option (Right to buy)
A - Award 28,628 28,628
2022-03-03 2022-03-01 4 GBT Global Blood Therapeutics, Inc.
Restricted Stock Units
A - Award 17,668 17,668
2022-03-03 2022-03-01 4 GBT Global Blood Therapeutics, Inc.
Restricted Stock Units
A - Award 17,668 17,668
2022-03-03 2022-03-01 4 GBT Global Blood Therapeutics, Inc.
Restricted Stock Units
M - Exercise -2,763 16,577 -14.29
2022-03-03 2022-03-01 4 GBT Global Blood Therapeutics, Inc.
Common Stock
F - Taxes -956 191,374 -0.50 29.87 -28,556 5,716,341
2022-03-03 2022-03-01 4 GBT Global Blood Therapeutics, Inc.
Common Stock
M - Exercise 2,763 192,330 1.46
2022-02-03 2022-02-01 4 GBT Global Blood Therapeutics, Inc.
Restricted Stock Units
M - Exercise -3,020 12,080 -20.00
2022-02-03 2022-02-01 4 GBT Global Blood Therapeutics, Inc.
Restricted Stock Units
M - Exercise -3,125 6,250 -33.33
2022-02-03 2022-02-01 4 GBT Global Blood Therapeutics, Inc.
Restricted Stock Units
M - Exercise -2,875 0 -100.00
2022-02-03 2022-02-01 4 GBT Global Blood Therapeutics, Inc.
Common Stock
F - Taxes -3,340 189,567 -1.73 29.33 -97,962 5,560,000
2022-02-03 2022-02-01 4 GBT Global Blood Therapeutics, Inc.
Common Stock
M - Exercise 9,020 192,907 4.91
2021-09-24 2021-08-01 4/A GBT Global Blood Therapeutics, Inc.
Restricted Stock Units
M - Exercise -3,020 15,100 -16.67
2021-09-24 2021-08-01 4/A GBT Global Blood Therapeutics, Inc.
Restricted Stock Units
M - Exercise -3,125 9,375 -25.00
2021-09-24 2021-08-01 4/A GBT Global Blood Therapeutics, Inc.
Restricted Stock Units
M - Exercise -2,875 2,875 -50.00
2021-09-24 2021-08-01 4/A GBT Global Blood Therapeutics, Inc.
Common Stock
F - Taxes -3,743 182,367 -2.01 27.33 -102,296 4,984,090
2021-09-24 2021-08-01 4/A GBT Global Blood Therapeutics, Inc.
Common Stock
M - Exercise 9,020 186,110 5.09
2021-09-03 2021-09-01 4 GBT Global Blood Therapeutics, Inc.
Restricted Stock Units
M - Exercise -2,762 19,340 -12.50
2021-09-03 2021-09-01 4 GBT Global Blood Therapeutics, Inc.
Common Stock
F - Taxes -1,370 183,887 -0.74 29.85 -40,894 5,489,027
2021-09-03 2021-09-01 4 GBT Global Blood Therapeutics, Inc.
Common Stock
M - Exercise 2,762 185,257 1.51
2021-09-03 2021-08-31 4 GBT Global Blood Therapeutics, Inc.
Common Stock
A - Award 128 182,495 0.07 24.39 3,122 4,451,053
2021-08-03 2021-08-01 4 GBT Global Blood Therapeutics, Inc.
Restricted Stock Units
M - Exercise -3,020 15,100 -16.67
2021-08-03 2021-08-01 4 GBT Global Blood Therapeutics, Inc.
Restricted Stock Units
M - Exercise -3,125 9,375 -25.00
2021-08-03 2021-08-01 4 GBT Global Blood Therapeutics, Inc.
Restricted Stock Units
M - Exercise -2,875 2,875 -50.00
2021-08-03 2021-08-01 4 GBT Global Blood Therapeutics, Inc.
Common Stock
F - Taxes -3,743 182,367 -2.01 27.33 -102,296 4,984,090
2021-08-03 2021-08-01 4 GBT Global Blood Therapeutics, Inc.
Common Stock
M - Exercise 9,020 186,110 5.09
2021-06-04 2021-06-02 4 ANNX Annexon, Inc.
Stock Option (Right to Buy)
A - Award 10,000 10,000
2021-03-03 2021-03-01 4 GBT Global Blood Therapeutics, Inc.
Restricted Stock Units
A - Award 22,102 22,102
2021-03-03 2021-03-01 4 GBT Global Blood Therapeutics, Inc.
Stock Option (Right to Buy)
A - Award 38,739 38,739
2021-03-03 2021-02-28 4 GBT Global Blood Therapeutics, Inc.
Common Stock
A - Award 140 177,090 0.08 36.21 5,069 6,412,429
2021-02-03 2021-02-01 4 GBT Global Blood Therapeutics, Inc.
Restricted Stock Units
M - Exercise -3,020 18,120 -14.29
2021-02-03 2021-02-01 4 GBT Global Blood Therapeutics, Inc.
Restricted Stock Units
M - Exercise -3,125 12,500 -20.00
2021-02-03 2021-02-01 4 GBT Global Blood Therapeutics, Inc.
Restricted Stock Units
M - Exercise -2,875 5,750 -33.33
2021-02-03 2021-02-01 4 GBT Global Blood Therapeutics, Inc.
Restricted Stock Units
M - Exercise -4,063 0 -100.00
2021-02-03 2021-02-01 4 GBT Global Blood Therapeutics, Inc.
Common Stock
F - Taxes -4,646 176,950 -2.56 49.49 -229,931 8,757,256
2021-02-03 2021-02-01 4 GBT Global Blood Therapeutics, Inc.
Common Stock
M - Exercise 13,083 181,596 7.76
2020-08-04 2020-08-01 4 GBT Global Blood Therapeutics, Inc.
Restricted Stock Units
M - Exercise -3,020 21,140 -12.50
2020-08-04 2020-08-01 4 GBT Global Blood Therapeutics, Inc.
Restricted Stock Units
M - Exercise -3,125 15,625 -16.67
2020-08-04 2020-08-01 4 GBT Global Blood Therapeutics, Inc.
Restricted Stock Units
M - Exercise -2,875 8,625 -25.00
2020-08-04 2020-08-01 4 GBT Global Blood Therapeutics, Inc.
Restricted Stock Units
M - Exercise -4,062 4,063 -49.99
2020-08-04 2020-08-01 4 GBT Global Blood Therapeutics, Inc.
Common Stock
F - Taxes -6,239 168,513 -3.57 67.48 -421,008 11,371,257
2020-08-04 2020-08-01 4 GBT Global Blood Therapeutics, Inc.
Common Stock
M - Exercise 13,082 174,752 8.09
2020-08-04 2020-07-31 4 GBT Global Blood Therapeutics, Inc.
Common Stock
A - Award 162 161,670 0.10 36.68 5,942 5,930,056
2020-06-03 2020-06-01 4 GBT Global Blood Therapeutics, Inc.
Restricted Stock Units
A - Award 42,400 42,400
2020-02-04 2020-02-03 4 GBT Global Blood Therapeutics, Inc.
Stock Option (Right to Buy)
A - Award 38,500 38,500
2020-02-04 2020-02-03 4 GBT Global Blood Therapeutics, Inc.
Restricted Stock Units
A - Award 24,160 24,160
2020-02-04 2020-02-01 4 GBT Global Blood Therapeutics, Inc.
Restricted Stock Units
M - Exercise -3,125 18,750 -14.29
2020-02-04 2020-02-01 4 GBT Global Blood Therapeutics, Inc.
Restricted Stock Units
M - Exercise -2,875 11,500 -20.00
2020-02-04 2020-02-01 4 GBT Global Blood Therapeutics, Inc.
Restricted Stock Units
M - Exercise -4,063 8,125 -33.34
2020-02-04 2020-02-01 4 GBT Global Blood Therapeutics, Inc.
Common Stock
F - Taxes -3,570 161,508 -2.16 65.26 -232,978 10,540,012
2020-02-04 2020-02-01 4 GBT Global Blood Therapeutics, Inc.
Common Stock
M - Exercise 10,063 165,078 6.49
2020-02-04 2020-01-31 4 GBT Global Blood Therapeutics, Inc.
Common Stock
A - Award 286 155,015 0.18 36.68 10,490 5,685,950
2019-12-17 2019-12-13 4 GBT Global Blood Therapeutics, Inc.
Restricted Stock Units
M - Exercise -5,000 0 -100.00
2019-12-17 2019-12-13 4 GBT Global Blood Therapeutics, Inc.
Common Stock
F - Taxes -2,479 154,729 -1.58 76.88 -190,586 11,895,566
2019-12-17 2019-12-13 4 GBT Global Blood Therapeutics, Inc.
Common Stock
M - Exercise 5,000 157,208 3.28
2019-08-05 2019-08-01 4 GBT Global Blood Therapeutics, Inc.
Restricted Stock Units
M - Exercise -3,125 21,875 -12.50
2019-08-05 2019-08-01 4 GBT Global Blood Therapeutics, Inc.
Restricted Stock Units
M - Exercise -2,875 14,375 -16.67
2019-08-05 2019-08-01 4 GBT Global Blood Therapeutics, Inc.
Restricted Stock Units
M - Exercise -4,062 12,188 -25.00
2019-08-05 2019-08-01 4 GBT Global Blood Therapeutics, Inc.
Common Stock
F - Taxes -3,990 152,208 -2.55 54.25 -216,458 8,257,284
2019-08-05 2019-08-01 4 GBT Global Blood Therapeutics, Inc.
Common Stock
M - Exercise 10,062 156,198 6.89
2019-08-05 2019-07-31 4 GBT Global Blood Therapeutics, Inc.
Common Stock
A - Award 285 146,136 0.20 36.68 10,454 5,360,268
2019-04-10 2019-04-08 4 GBT Global Blood Therapeutics, Inc.
Restricted Stock Units
M - Exercise -2,000 5,000 -28.57
2019-04-10 2019-04-08 4 GBT Global Blood Therapeutics, Inc.
Common Stock
F - Taxes -692 145,851 -0.47 58.51 -40,489 8,533,742
2019-04-10 2019-04-08 4 GBT Global Blood Therapeutics, Inc.
Common Stock
M - Exercise 2,000 146,543 1.38
2019-04-10 2019-01-31 4 GBT Global Blood Therapeutics, Inc.
Common Stock
A - Award 269 144,543 0.19 36.68 9,867 5,301,837
2019-02-14 2018-07-31 5 GBT Global Blood Therapeutics, Inc.
Common Stock
A - Award 277 144,274 0.19 35.53 9,842 5,126,055
2019-02-05 2019-02-01 4 GBT Global Blood Therapeutics, Inc.
Restricted Stock Units
M - Exercise -2,875 17,250 -14.29
2019-02-05 2019-02-01 4 GBT Global Blood Therapeutics, Inc.
Restricted Stock Units
M - Exercise -4,063 16,250 -20.00
2019-02-05 2019-02-01 4 GBT Global Blood Therapeutics, Inc.
Restricted Stock Units
A - Award 25,000 25,000
2019-02-05 2019-02-01 4 GBT Global Blood Therapeutics, Inc.
Stock Option (Right to Buy)
A - Award 40,000 40,000
2019-02-05 2019-02-01 4 GBT Global Blood Therapeutics, Inc.
Common Stock
F - Taxes -2,515 143,997 -1.72 48.44 -121,827 6,975,215
2019-02-05 2019-02-01 4 GBT Global Blood Therapeutics, Inc.
Common Stock
M - Exercise 6,938 146,512 4.97
2018-08-03 2018-08-01 4 GBT Global Blood Therapeutics, Inc.
Restricted Stock Units
M - Exercise -2,875 20,125 -12.50
2018-08-03 2018-08-01 4 GBT Global Blood Therapeutics, Inc.
Restricted Stock Units
M - Exercise -4,062 20,313 -16.66
2018-08-03 2018-08-01 4 GBT Global Blood Therapeutics, Inc.
Common Stock
F - Taxes -3,440 139,574 -2.41 43.15 -148,436 6,022,618
2018-08-03 2018-08-01 4 GBT Global Blood Therapeutics, Inc.
Common Stock
M - Exercise 6,937 143,014 5.10
2018-05-21 2018-05-17 4 GBT Global Blood Therapeutics, Inc.
Stock Option (Right to Buy)
M - Exercise -601 2,675 -18.35
2018-05-21 2018-05-17 4 GBT Global Blood Therapeutics, Inc.
Stock Option (Right to Buy)
M - Exercise -601 2,675 -18.35
2018-05-21 2018-05-17 4 GBT Global Blood Therapeutics, Inc.
Stock Option (Right to Buy)
M - Exercise -198 74,964 -0.26
2018-05-21 2018-05-17 4 GBT Global Blood Therapeutics, Inc.
Common Stock
S - Sale X -1,400 136,077 -1.02 48.25 -67,550 6,565,715
2018-05-21 2018-05-17 4 GBT Global Blood Therapeutics, Inc.
Common Stock
M - Exercise 601 137,477 0.44 3.40 2,043 467,422
2018-05-21 2018-05-17 4 GBT Global Blood Therapeutics, Inc.
Common Stock
M - Exercise 601 137,477 0.44 3.40 2,043 467,422
2018-05-21 2018-05-17 4 GBT Global Blood Therapeutics, Inc.
Common Stock
M - Exercise 198 136,275 0.15 3.40 673 463,335
2018-05-21 2018-05-17 4 GBT Global Blood Therapeutics, Inc.
Common Stock
S - Sale X -1,600 136,077 -1.16 48.25 -77,200 6,565,715
2018-04-19 2018-04-17 4 GBT Global Blood Therapeutics, Inc.
Stock Option (Right to Buy)
M - Exercise -601 3,276 -15.50
2018-04-19 2018-04-17 4 GBT Global Blood Therapeutics, Inc.
Stock Option (Right to Buy)
M - Exercise -601 3,276 -15.50
2018-04-19 2018-04-17 4 GBT Global Blood Therapeutics, Inc.
Stock Option (Right to Buy)
M - Exercise -198 75,162 -0.26
2018-04-19 2018-04-17 4 GBT Global Blood Therapeutics, Inc.
Common Stock
S - Sale X -1,400 137,677 -1.01 45.50 -63,700 6,264,304
2018-04-19 2018-04-17 4 GBT Global Blood Therapeutics, Inc.
Common Stock
M - Exercise 601 139,077 0.43 3.40 2,043 472,862
2018-04-19 2018-04-17 4 GBT Global Blood Therapeutics, Inc.
Common Stock
M - Exercise 601 139,077 0.43 3.40 2,043 472,862
2018-04-19 2018-04-17 4 GBT Global Blood Therapeutics, Inc.
Common Stock
M - Exercise 198 137,875 0.14 3.40 673 468,775
2018-04-19 2018-04-17 4 GBT Global Blood Therapeutics, Inc.
Common Stock
S - Sale X -1,600 137,677 -1.15 45.50 -72,800 6,264,304
2018-03-20 2018-03-16 4 GBT Global Blood Therapeutics, Inc.
Stock Option (Right to Buy)
M - Exercise -601 3,877 -13.42
2018-03-20 2018-03-16 4 GBT Global Blood Therapeutics, Inc.
Stock Option (Right to Buy)
M - Exercise -601 3,877 -13.42
2018-03-20 2018-03-16 4 GBT Global Blood Therapeutics, Inc.
Stock Option (Right to Buy)
M - Exercise -198 75,360 -0.26
2018-03-20 2018-03-16 4 GBT Global Blood Therapeutics, Inc.
Common Stock
S - Sale X -1,400 139,277 -1.00 54.15 -75,810 7,541,850
2018-03-20 2018-03-16 4 GBT Global Blood Therapeutics, Inc.
Common Stock
M - Exercise 601 140,677 0.43 3.40 2,043 478,302
2018-03-20 2018-03-16 4 GBT Global Blood Therapeutics, Inc.
Common Stock
M - Exercise 601 140,677 0.43 3.40 2,043 478,302
2018-03-20 2018-03-16 4 GBT Global Blood Therapeutics, Inc.
Common Stock
M - Exercise 198 139,475 0.14 3.40 673 474,215
2018-03-20 2018-03-16 4 GBT Global Blood Therapeutics, Inc.
Common Stock
S - Sale X -1,600 139,277 -1.14 54.15 -86,640 7,541,850
2018-02-21 2018-02-16 4 GBT Global Blood Therapeutics, Inc.
Stock Option (Right to Buy)
M - Exercise -601 4,478 -11.83
2018-02-21 2018-02-16 4 GBT Global Blood Therapeutics, Inc.
Stock Option (Right to Buy)
M - Exercise -601 4,478 -11.83
2018-02-21 2018-02-16 4 GBT Global Blood Therapeutics, Inc.
Stock Option (Right to Buy)
M - Exercise -198 75,558 -0.26
2018-02-21 2018-02-16 4 GBT Global Blood Therapeutics, Inc.
Common Stock
S - Sale X -1,400 140,877 -0.98 62.95 -88,130 8,868,207
2018-02-21 2018-02-16 4 GBT Global Blood Therapeutics, Inc.
Common Stock
M - Exercise 601 142,277 0.42 3.40 2,043 483,742
2018-02-21 2018-02-16 4 GBT Global Blood Therapeutics, Inc.
Common Stock
M - Exercise 601 142,277 0.42 3.40 2,043 483,742
2018-02-21 2018-02-16 4 GBT Global Blood Therapeutics, Inc.
Common Stock
M - Exercise 198 141,075 0.14 3.40 673 479,655
2018-02-21 2018-02-16 4 GBT Global Blood Therapeutics, Inc.
Common Stock
S - Sale X -1,600 140,877 -1.12 62.95 -100,720 8,868,207
2018-02-16 2018-02-14 4 GBT Global Blood Therapeutics, Inc.
Restricted Stock Units
M - Exercise -2,000 7,000 -22.22
2018-02-16 2018-02-14 4 GBT Global Blood Therapeutics, Inc.
Common Stock
F - Taxes -692 142,477 -0.48 62.30 -43,112 8,876,317
2018-02-16 2018-02-14 4 GBT Global Blood Therapeutics, Inc.
Common Stock
M - Exercise 2,000 143,169 1.42
2018-02-14 2017-07-31 5 GBT Global Blood Therapeutics, Inc.
Common Stock
A - Award 676 135,931 0.50 13.69 9,254 1,860,895
2018-02-02 2018-02-01 4 GBT Global Blood Therapeutics, Inc.
Restricted Stock Units
A - Award 23,000 23,000
2018-02-02 2018-02-01 4 GBT Global Blood Therapeutics, Inc.
Stock Option (Right to Buy)
A - Award 35,000 35,000
2018-02-02 2018-02-01 4 GBT Global Blood Therapeutics, Inc.
Restricted Stock Units
M - Exercise -4,063 24,375 -14.29
2018-02-02 2018-02-01 4 GBT Global Blood Therapeutics, Inc.
Common Stock
F - Taxes -1,405 140,058 -0.99 59.60 -83,738 8,347,457
2018-02-02 2018-02-01 4 GBT Global Blood Therapeutics, Inc.
Common Stock
M - Exercise 4,063 141,463 2.96
2018-02-02 2018-01-31 4 GBT Global Blood Therapeutics, Inc.
Restricted Stock Units
M - Exercise -2,000 9,000 -18.18
2018-02-02 2018-01-31 4 GBT Global Blood Therapeutics, Inc.
Common Stock
F - Taxes -692 137,400 -0.50 57.90 -40,067 7,955,460
2018-02-02 2018-01-31 4 GBT Global Blood Therapeutics, Inc.
Common Stock
M - Exercise 2,000 138,092 1.47
2018-01-26 2018-01-24 4 GBT Global Blood Therapeutics, Inc.
Restricted Stock Units
M - Exercise -2,000 11,000 -15.38
2018-01-26 2018-01-24 4 GBT Global Blood Therapeutics, Inc.
Common Stock
F - Taxes -686 136,092 -0.50 58.15 -39,891 7,913,750
2018-01-26 2018-01-24 4 GBT Global Blood Therapeutics, Inc.
Common Stock
M - Exercise 2,000 136,778 1.48
2018-01-18 2018-01-17 4 GBT Global Blood Therapeutics, Inc.
Employee Stock Option (Right to Buy)
M - Exercise -601 5,079 -10.58
2018-01-18 2018-01-17 4 GBT Global Blood Therapeutics, Inc.
Employee Stock Option (Right to Buy)
M - Exercise -601 5,079 -10.58
2018-01-18 2018-01-17 4 GBT Global Blood Therapeutics, Inc.
Employee Stock Option (Right to Buy)
M - Exercise -198 75,756 -0.26
2018-01-18 2018-01-17 4 GBT Global Blood Therapeutics, Inc.
Common Stock
S - Sale X -1,600 134,778 -1.17 52.85 -84,560 7,123,017
2018-01-18 2018-01-17 4 GBT Global Blood Therapeutics, Inc.
Common Stock
S - Sale X -1,400 136,378 -1.02 52.85 -73,990 7,207,577
2018-01-18 2018-01-17 4 GBT Global Blood Therapeutics, Inc.
Common Stock
M - Exercise 601 137,778 0.44 3.40 2,043 468,445
2018-01-18 2018-01-17 4 GBT Global Blood Therapeutics, Inc.
Common Stock
M - Exercise 601 137,778 0.44 3.40 2,043 468,445
2018-01-18 2018-01-17 4 GBT Global Blood Therapeutics, Inc.
Common Stock
M - Exercise 198 136,576 0.15 3.40 673 464,358
2018-01-18 2018-01-16 4 GBT Global Blood Therapeutics, Inc.
Restricted Stock Units
M - Exercise -2,000 13,000 -13.33
2018-01-18 2018-01-16 4 GBT Global Blood Therapeutics, Inc.
Common Stock
F - Taxes -877 136,378 -0.64 52.10 -45,692 7,105,294
2018-01-18 2018-01-16 4 GBT Global Blood Therapeutics, Inc.
Common Stock
M - Exercise 2,000 137,255 1.48
2017-12-20 2017-12-18 4 GBT Global Blood Therapeutics, Inc.
Employee Stock Option (right to buy)
M - Exercise -601 5,680 -9.57
2017-12-20 2017-12-18 4 GBT Global Blood Therapeutics, Inc.
Employee Stock Option (right to buy)
M - Exercise -601 5,680 -9.57
2017-12-20 2017-12-18 4 GBT Global Blood Therapeutics, Inc.
Employee Stock Option (right to buy)
M - Exercise -198 75,954 -0.26
2017-12-20 2017-12-18 4 GBT Global Blood Therapeutics, Inc.
Common Stock
S - Sale X -1,400 135,255 -1.02 36.55 -51,170 4,943,570
2017-12-20 2017-12-18 4 GBT Global Blood Therapeutics, Inc.
Common Stock
M - Exercise 601 136,655 0.44 3.40 2,043 464,627
2017-12-20 2017-12-18 4 GBT Global Blood Therapeutics, Inc.
Common Stock
M - Exercise 601 136,655 0.44 3.40 2,043 464,627
2017-12-20 2017-12-18 4 GBT Global Blood Therapeutics, Inc.
Common Stock
M - Exercise 198 135,453 0.15 3.40 673 460,540
2017-12-20 2017-12-18 4 GBT Global Blood Therapeutics, Inc.
Common Stock
S - Sale X -1,600 135,255 -1.17 36.55 -58,480 4,943,570
2017-11-21 2017-11-17 4 GBT Global Blood Therapeutics, Inc.
Employee Stock Option (right to buy)
M - Exercise -601 6,281 -8.73
2017-11-21 2017-11-17 4 GBT Global Blood Therapeutics, Inc.
Employee Stock Option (right to buy)
M - Exercise -601 6,281 -8.73
2017-11-21 2017-11-17 4 GBT Global Blood Therapeutics, Inc.
Employee Stock Option (right to buy)
M - Exercise -198 76,152 -0.26
2017-11-21 2017-11-17 4 GBT Global Blood Therapeutics, Inc.
Common Stock
S - Sale X -1,400 136,855 -1.01 39.75 -55,650 5,439,986
2017-11-21 2017-11-17 4 GBT Global Blood Therapeutics, Inc.
Common Stock
M - Exercise 601 138,255 0.44 3.40 2,043 470,067
2017-11-21 2017-11-17 4 GBT Global Blood Therapeutics, Inc.
Common Stock
M - Exercise 601 138,255 0.44 3.40 2,043 470,067
2017-11-21 2017-11-17 4 GBT Global Blood Therapeutics, Inc.
Common Stock
M - Exercise 198 137,053 0.14 3.40 673 465,980
2017-11-21 2017-11-17 4 GBT Global Blood Therapeutics, Inc.
Common Stock
S - Sale X -1,600 136,855 -1.16 39.75 -63,600 5,439,986
2017-10-18 2017-10-17 4 GBT Global Blood Therapeutics, Inc.
Employee Stock Option (right to buy)
M - Exercise -601 6,882 -8.03
2017-10-18 2017-10-17 4 GBT Global Blood Therapeutics, Inc.
Employee Stock Option (right to buy)
M - Exercise -601 6,882 -8.03
2017-10-18 2017-10-17 4 GBT Global Blood Therapeutics, Inc.
Employee Stock Option (right to buy)
M - Exercise -198 76,350 -0.26
2017-10-18 2017-10-17 4 GBT Global Blood Therapeutics, Inc.
Common Stock
S - Sale X -1,400 138,455 -1.00 32.65 -45,710 4,520,556
2017-10-18 2017-10-17 4 GBT Global Blood Therapeutics, Inc.
Common Stock
M - Exercise 601 139,855 0.43 3.40 2,043 475,507
2017-10-18 2017-10-17 4 GBT Global Blood Therapeutics, Inc.
Common Stock
M - Exercise 601 139,855 0.43 3.40 2,043 475,507
2017-10-18 2017-10-17 4 GBT Global Blood Therapeutics, Inc.
Common Stock
M - Exercise 198 138,653 0.14 3.40 673 471,420
2017-10-18 2017-10-17 4 GBT Global Blood Therapeutics, Inc.
Common Stock
S - Sale X -1,600 138,455 -1.14 32.65 -52,240 4,520,556
2017-10-02 2017-09-29 4 GBT Global Blood Therapeutics, Inc.
Employee Stock Option (right to buy)
M - Exercise -601 7,483 -7.43
2017-10-02 2017-09-29 4 GBT Global Blood Therapeutics, Inc.
Employee Stock Option (right to buy)
M - Exercise -601 7,483 -7.43
2017-10-02 2017-09-29 4 GBT Global Blood Therapeutics, Inc.
Employee Stock Option (right to buy)
M - Exercise -198 76,548 -0.26
2017-10-02 2017-09-29 4 GBT Global Blood Therapeutics, Inc.
Common Stock
S - Sale X -1,400 140,055 -0.99 30.00 -42,000 4,201,650
2017-10-02 2017-09-29 4 GBT Global Blood Therapeutics, Inc.
Common Stock
M - Exercise 601 141,455 0.43 3.40 2,043 480,947
2017-10-02 2017-09-29 4 GBT Global Blood Therapeutics, Inc.
Common Stock
M - Exercise 601 141,455 0.43 3.40 2,043 480,947
2017-10-02 2017-09-29 4 GBT Global Blood Therapeutics, Inc.
Common Stock
M - Exercise 198 140,253 0.14 3.40 673 476,860
2017-10-02 2017-09-29 4 GBT Global Blood Therapeutics, Inc.
Common Stock
S - Sale X -1,600 140,055 -1.13 30.00 -48,000 4,201,650
2017-09-05 2017-08-31 4 GBT Global Blood Therapeutics, Inc.
Employee Stock Option (right to buy)
M - Exercise -601 8,084 -6.92
2017-09-05 2017-08-31 4 GBT Global Blood Therapeutics, Inc.
Employee Stock Option (right to buy)
M - Exercise -601 8,084 -6.92
2017-09-05 2017-08-31 4 GBT Global Blood Therapeutics, Inc.
Employee Stock Option (right to buy)
M - Exercise -198 76,746 -0.26
2017-09-05 2017-08-31 4 GBT Global Blood Therapeutics, Inc.
Common Stock
S - Sale X -1,400 141,655 -0.98 30.00 -42,000 4,249,650
2017-09-05 2017-08-31 4 GBT Global Blood Therapeutics, Inc.
Common Stock
M - Exercise 601 143,055 0.42 3.40 2,043 486,387
2017-09-05 2017-08-31 4 GBT Global Blood Therapeutics, Inc.
Common Stock
M - Exercise 601 143,055 0.42 3.40 2,043 486,387
2017-09-05 2017-08-31 4 GBT Global Blood Therapeutics, Inc.
Common Stock
M - Exercise 198 141,853 0.14 3.40 673 482,300
2017-09-05 2017-08-31 4 GBT Global Blood Therapeutics, Inc.
Common Stock
S - Sale X -1,600 141,655 -1.12 30.00 -48,000 4,249,650
2017-08-14 2017-08-11 4 GBT Global Blood Therapeutics, Inc.
Restricted Stock Units
A - Award 15,000 15,000
2017-08-03 2017-08-01 4 GBT Global Blood Therapeutics, Inc.
Restricted Stock Units
M - Exercise -4,062 28,438 -12.50
2017-08-03 2017-08-01 4 GBT Global Blood Therapeutics, Inc.
Common Stock
F - Taxes -1,527 145,790 -1.04 25.10 -38,328 3,659,329
2017-08-03 2017-08-01 4 GBT Global Blood Therapeutics, Inc.
Common Stock
M - Exercise 4,062 147,317 2.84
2017-07-25 2017-07-21 4 GBT Global Blood Therapeutics, Inc.
Employee Stock Option (right to buy)
M - Exercise -601 8,685 -6.47
2017-07-25 2017-07-21 4 GBT Global Blood Therapeutics, Inc.
Employee Stock Option (right to buy)
M - Exercise -601 8,685 -6.47
2017-07-25 2017-07-21 4 GBT Global Blood Therapeutics, Inc.
Employee Stock Option (right to buy)
M - Exercise -198 76,944 -0.26
2017-07-25 2017-07-21 4 GBT Global Blood Therapeutics, Inc.
Common Stock
S - Sale X -1,400 143,255 -0.97 30.00 -42,000 4,297,650
2017-07-25 2017-07-21 4 GBT Global Blood Therapeutics, Inc.
Common Stock
M - Exercise 601 144,655 0.42 3.40 2,043 491,827
2017-07-25 2017-07-21 4 GBT Global Blood Therapeutics, Inc.
Common Stock
M - Exercise 601 144,655 0.42 3.40 2,043 491,827
2017-07-25 2017-07-21 4 GBT Global Blood Therapeutics, Inc.
Common Stock
M - Exercise 198 143,453 0.14 3.40 673 487,740
2017-07-25 2017-07-21 4 GBT Global Blood Therapeutics, Inc.
Common Stock
S - Sale X -1,600 143,255 -1.10 30.00 -48,000 4,297,650
2017-02-14 2017-01-31 5 GBT Global Blood Therapeutics, Inc.
Common Stock
A - Award 658 144,855 0.46 13.73 9,034 1,988,859
2017-02-14 2016-07-31 5 GBT Global Blood Therapeutics, Inc.
Common Stock
A - Award 591 144,197 0.41 15.20 8,983 2,191,794
2017-01-19 2017-01-17 4 GBT Global Blood Therapeutics, Inc.
Stock Option (right to buy)
A - Award 49,000 49,000
2017-01-19 2017-01-17 4 GBT Global Blood Therapeutics, Inc.
Restricted Stock Units
A - Award 32,500 32,500
2016-10-03 2016-09-29 4 GBT Global Blood Therapeutics, Inc.
Employee Stock Option (Right to Buy)
A - Award 9,286 9,286
2016-03-14 2016-03-10 4 GBT Global Blood Therapeutics, Inc.
Employee Stock Option (Right to Buy)
A - Award 9,286 9,286
2016-03-14 2016-02-01 4/A GBT Global Blood Therapeutics, Inc.
Common Stock
A - Award 749 143,606 0.52 16.09 12,051 2,310,621
2016-03-14 2015-08-17 4/A GBT Global Blood Therapeutics, Inc.
Common Stock
P - Purchase 25,000 25,000 20.00 500,000 500,000
2016-02-03 2016-02-01 4 GBT Global Blood Therapeutics, Inc.
Common Stock
A - Award 749 168,606 0.45 16.09 12,051 2,712,871
2016-01-07 2015-08-17 4 GBT Global Blood Therapeutics, Inc.
Common Stock
P - Purchase 25,000 167,857 17.50 20.00 500,000 3,357,140
2015-08-11 3 GBT Global Blood Therapeutics, Inc.
Common Stock
285,714
2015-08-11 3 GBT Global Blood Therapeutics, Inc.
Common Stock
285,714
P
非衍生或衍生證券的公開市場或私下買入
S
非衍生或衍生證券的公開市場或私下賣出
A
公司向內部人員授予、獎勵或以其他方式獲取證券(例如股票期權)
C
衍生工具轉換
D
將證券賣出或轉讓回公司
F
使用從公司收到的證券的一部分來支付行使價或稅務負擔。
G
內部人士贈送或接收他人贈送公司股票
K
股權掉期和類似的避險交易
M
行使或轉換從公司獲得的衍生證券(例如期權)
V
內部人士透過Form 4自願報告的一筆交易
J
其他(附有交易描述的腳註)